Trial Profile
An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs Topiroxostat (Primary) ; Warfarin
- Indications Diabetic nephropathies; Gout; Hyperuricaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Sanwa Kagaku Kenkyusho
- 02 Jun 2016 New trial record